MENA Mesotherapy Market: Current Analysis and Forecast (2023-2030)

Mesotherapy is used with microneedling and other skin rejuvenation techniques, amplifying the benefits of these procedures by delivering active ingredients deeper into the skin layers for enhanced collagen production and skin renewal. However, this segment caters to individuals undergoing cosmetic procedures such as facelifts, liposuction, and laser treatments, providing complementary skincare solutions that optimize results and promote recovery.

The MENA Mesotherapy Market is expected to grow at a strong CAGR of 6.14% during the forecast period (2023-2030). The growing awareness and emphasis on skincare and aesthetic treatments among consumers in the MENA region drive the demand for mesotherapy services. As per the recent report, Dubai Health Authority figures showed the number of people seeking cosmetic procedures has risen sharply since the onset of COVID-19, up from 223,507 in 2020 to 583,909 in 2022. Moreover, the aging demographic in the region fuels demand for anti-aging treatments like mesotherapy and initiating opportunities for market expansion.

Based on type, the market is segmented into mesotherapy solutions, mesotherapy masks, mesotherapy creams, mesotherapy devices, and others. Among them, the mesotherapy solutions category held the largest share of the market in 2022. This is mainly due to the increasing demand for personalized skincare solutions tailored to individual skin types and concerns. For instance, on March 11, 2024, Formycon AG and MS Pharma announced the launch of FYB201/Ravegza, a biosimilar to Lucentis that received marketing authorization from the Saudi Food & Drug Authority. Ravegza was approved in Saudi Arabia for the treatment of patients with age-related neovascular (wet) macular degeneration (nAMD).

By application, the market is segmented into facial rejuvenation, anti-aging, stretch marks, acne & scar treatment, fat removal, hair removal, and others. Among them, the anti-aging category held the largest share of the market in 2022. This is mainly due to the the growing awareness and acceptance of preventive skin care measures among consumers which leads to increased demand for anti-aging treatments at earlier ages.

Based on the end user, the market is categorized into dermatology & cosmetic clinics, hospitals, and others. Among these, the hospitals category is expected to grow with a significant CAGR during the forecast period (2023-2030). This is mainly due to hospitals offering integrated skincare and aesthetic services under medical supervision and collaborating with dermatologists and plastic surgeons to provide holistic treatment plans, thus driving mesotherapy's growth and adoption in hospital settings across the region. Moreover, the trust and credibility associated with hospitals attract a diverse patient base seeking professional and medically supervised skincare solutions.

For a better understanding of the market adoption of the Mesotherapy industry, the MENA market is analyzed based on its worldwide presence in countries such as UAE, Saudi Arabia, Egypt, Kuwait, and the Rest of the MENA. Saudi Arabia held a dominant share of the market in 2022 due to the country's increasing beauty and wellness industry coupled with a rising trend of cosmetic procedures among both men and women propel the demand for mesotherapy treatments. For instance, in 2023, DermTech, investment to revolutionize skincare. DermTech utilizes cutting-edge technology like artificial intelligence and offers online dermatologist consultations to create personalized skin care regimens for consumers. Adding to this is the increasing adoption of combination therapies where mesotherapy is complemented with other non-invasive procedures like laser treatments for comprehensive skincare solutions.

Some of the major players operating in the market include Maria Trading, mesoskinline, Koru Pharma Co., LTD., Silkor Laser & Aesthetic Center, APTOS LLC, Mediclinic Middle East, Hair Transplant Dubai, Viora, Dermapen, Arabian Medical Enterprises.